Want to see IN:UNICHEMLAB full AI Analyst Report?
Unichem Laboratories Limited (UNICHEMLAB) Ratios
Unichem Laboratories Limited Ratios
IN:UNICHEMLAB's free cash flow for Q1 2027 was $0.00. For the 2027 fiscal year, IN:UNICHEMLAB's free cash flow was increased by $0.00 and operating cash flow was $0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 2.48 | 2.05 | 2.39 | 2.48 | 2.98 |
| Quick Ratio | 1.38 | 1.06 | 1.40 | 1.51 | 1.89 |
| Cash Ratio | 0.33 | 0.09 | 0.21 | 0.29 | 0.20 |
| Solvency Ratio | 0.37 | 0.23 | 0.05 | -0.12 | 0.18 |
| Operating Cash Flow Ratio | -0.02 | -0.01 | 0.02 | -0.13 | -0.47 |
| Short-Term Operating Cash Flow Coverage | -0.04 | -0.02 | 0.09 | -0.36 | -1.08 |
| Net Current Asset Value | $ 11.77B | $ 9.19B | $ 8.87B | $ 8.31B | $ 9.45B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.13 | 0.13 | 0.08 | 0.10 | 0.11 |
| Debt-to-Equity Ratio | 0.18 | 0.19 | 0.10 | 0.13 | 0.13 |
| Debt-to-Capital Ratio | 0.16 | 0.16 | 0.09 | 0.11 | 0.12 |
| Long-Term Debt-to-Capital Ratio | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
| Financial Leverage Ratio | 1.38 | 1.46 | 1.34 | 1.31 | 1.27 |
| Debt Service Coverage Ratio | 0.89 | 0.64 | 0.32 | -0.28 | 0.52 |
| Interest Coverage Ratio | 1.87 | 40.18 | -0.57 | -9.99 | -3.99 |
| Debt to Market Cap | 0.23 | 0.09 | 0.06 | 0.15 | 0.18 |
| Interest Debt Per Share | 75.52 | 68.07 | 38.38 | 47.07 | 50.47 |
| Net Debt to EBITDA | 0.47 | 1.40 | 1.30 | -2.86 | 2.03 |
| Profitability Margins | |||||
| Gross Profit Margin | 29.95% | 59.09% | 19.15% | 59.76% | 64.30% |
| EBIT Margin | 14.71% | 6.65% | -2.35% | -12.00% | -0.87% |
| EBITDA Margin | 20.40% | 12.55% | 4.48% | -3.44% | 9.41% |
| Operating Profit Margin | 2.68% | 40.03% | -0.78% | -13.04% | -1.94% |
| Pretax Profit Margin | 13.28% | 7.32% | -3.72% | -13.31% | 1.75% |
| Net Profit Margin | 11.48% | 6.51% | -4.25% | -15.26% | 2.63% |
| Continuous Operations Profit Margin | 11.48% | 6.51% | -4.25% | -15.26% | 2.63% |
| Net Income Per EBT | 86.48% | 88.96% | 114.28% | 114.67% | 150.49% |
| EBT Per EBIT | 495.14% | 18.29% | 474.62% | 102.02% | -90.20% |
| Return on Assets (ROA) | 6.77% | 3.85% | -2.22% | -6.33% | 1.00% |
| Return on Equity (ROE) | 9.30% | 5.61% | -2.98% | -8.30% | 1.26% |
| Return on Capital Employed (ROCE) | 2.07% | 32.82% | -0.53% | -6.77% | -0.88% |
| Return on Invested Capital (ROIC) | 1.55% | 25.49% | -0.49% | -6.19% | -0.81% |
| Return on Tangible Assets | 6.78% | 3.87% | -2.24% | -6.34% | 1.00% |
| Earnings Yield | 12.24% | 2.80% | -2.03% | -9.92% | 1.81% |
| Efficiency Ratios | |||||
| Receivables Turnover | 2.66 | 2.71 | 2.72 | 2.22 | 2.47 |
| Payables Turnover | 4.32 | 2.15 | 4.48 | 1.90 | 2.40 |
| Inventory Turnover | 1.58 | 0.87 | 1.90 | 0.88 | 0.73 |
| Fixed Asset Turnover | 1.69 | 1.61 | 1.25 | 0.95 | 0.85 |
| Asset Turnover | 0.59 | 0.59 | 0.52 | 0.42 | 0.38 |
| Working Capital Turnover Ratio | 1.87 | 2.08 | 1.71 | 1.30 | 1.28 |
| Cash Conversion Cycle | 283.70 | 382.39 | 244.83 | 385.92 | 493.15 |
| Days of Sales Outstanding | 137.36 | 134.66 | 134.42 | 164.28 | 147.63 |
| Days of Inventory Outstanding | 230.74 | 417.86 | 191.95 | 414.23 | 497.30 |
| Days of Payables Outstanding | 84.40 | 170.12 | 81.55 | 192.59 | 151.78 |
| Operating Cycle | 368.10 | 552.52 | 326.37 | 578.51 | 644.93 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.23 | -0.99 | 2.37 | -12.09 | -36.88 |
| Free Cash Flow Per Share | -19.70 | -20.44 | -0.83 | -18.38 | -54.92 |
| Dividend Paid and CapEx Coverage Ratio | -0.13 | -0.05 | 0.73 | -1.17 | -1.67 |
| Capital Expenditure Coverage Ratio | -0.13 | -0.05 | 0.74 | -1.92 | -2.04 |
| Operating Cash Flow Coverage Ratio | -0.03 | -0.02 | 0.07 | -0.27 | -0.74 |
| Operating Cash Flow to Sales Ratio | -0.01 | -0.00 | 0.01 | -0.06 | -0.21 |
| Free Cash Flow Yield | -6.71% | -2.94% | -0.17% | -6.35% | -21.13% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 8.17 | 35.56 | -49.22 | -10.08 | 55.33 |
| Price-to-Sales (P/S) Ratio | 0.94 | 2.32 | 2.09 | 1.54 | 1.46 |
| Price-to-Book (P/B) Ratio | 0.76 | 2.00 | 1.47 | 0.84 | 0.70 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -14.89 | -33.98 | -592.62 | -15.76 | -4.73 |
| Price-to-Operating Cash Flow Ratio | -131.69 | -698.77 | 207.79 | -23.97 | -7.05 |
| Price-to-Earnings Growth (PEG) Ratio | 0.10 | -0.12 | 0.76 | 0.01 | -15.00 |
| Enterprise Value Multiple | 5.07 | 19.92 | 48.03 | -47.57 | 17.51 |
| Enterprise Value | 22.77B | 52.76B | 35.65B | 21.70B | 20.69B |
| EV to EBITDA | 5.07 | 19.92 | 48.03 | -47.57 | 17.51 |
| EV to Sales | 1.03 | 2.50 | 2.15 | 1.64 | 1.65 |
| EV to Free Cash Flow | -16.41 | -36.54 | -609.13 | -16.77 | -5.35 |
| EV to Operating Cash Flow | -145.11 | -751.51 | 213.57 | -25.50 | -7.97 |
| Tangible Book Value Per Share | 384.69 | 344.08 | 332.68 | 345.75 | 371.76 |
| Shareholders’ Equity Per Share | 385.95 | 346.95 | 335.55 | 345.97 | 371.98 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.14 | 0.11 | -0.14 | -0.15 | -0.50 |
| Revenue Per Share | 312.72 | 298.87 | 235.42 | 188.30 | 178.40 |
| Net Income Per Share | 35.91 | 19.47 | -10.01 | -28.73 | 4.70 |
| Tax Burden | 0.86 | 0.89 | 1.14 | 1.15 | 1.50 |
| Interest Burden | 0.90 | 1.10 | 1.58 | 1.11 | -2.02 |
| Research & Development to Revenue | 0.00 | 0.01 | 0.06 | 0.08 | 0.09 |
| SG&A to Revenue | 0.27 | 0.20 | 0.03 | 0.03 | 0.03 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | -0.06 | -0.05 | -0.24 | 0.48 | -11.82 |
Currency in INR